EQ Stock Analysis: Buy, Sell, or Hold?
EQ - Equillium, Inc. Common Stock
$2.20
0.00 (0.00%)
▲
5d:
-10.57%
30d:
-24.4%
90d:
+5.77%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When EQ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EQ shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EQ shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EQ is currently trading at $2.20, which is considered oversold relative to its 30-day fair value range of $2.57 to $3.02.
Technical Outlook: Technically, EQ is in a strong uptrend. The price is currently testing key support at $2.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EQ has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.56 (+288.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EQ is in a strong uptrend. The price is currently testing key support at $2.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EQ has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.56 (+288.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.57 -
$3.02
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 288.9% below Wall St target ($8.56)
- CAUTION: 5-day price weakness (-10.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.57 -
$3.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.15
Resistance Level
$2.86
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.28
Wall Street Target
$8.56
(+288.9%)
Revenue Growth (YoY)
-52.3%
Share & Embed Analysis
Last updated: August 04, 2026 5:42 AM ET
Data refreshes hourly during market hours. Next update: 6:42 AM
Data refreshes hourly during market hours. Next update: 6:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EQ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Christine Zedelmayer
SELL
120312 shares
2026-03-13
Christine Zedelmayer
SELL
181219 shares
2026-03-09
Christine Zedelmayer
SELL
185937 shares
2026-02-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 46 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 54 HOLD |